- Home
- RPRX vs TLN Comparison
RPRX vs TLN Comparison
Compare RPRX & TLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RPRX | TLN |
|---|---|---|
| Founded | 1996 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.2B | 18.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPRX | TLN |
|---|---|---|
| Price | $39.70 | $354.06 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 13 |
| Target Price | $46.00 | ★ $415.38 |
| AVG Volume (30 Days) | ★ 4.3M | 900.2K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | ★ 2.21% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 1.75 | ★ 4.55 |
| Revenue | ★ $2,349,844,000.00 | $2,343,000,000.00 |
| Revenue This Year | $37.13 | $13.07 |
| Revenue Next Year | $1.48 | $73.72 |
| P/E Ratio | ★ $22.68 | $77.79 |
| Revenue Growth | 3.70 | ★ 16.22 |
| 52 Week Low | $24.05 | $158.08 |
| 52 Week High | $41.24 | $451.28 |
Technical Indicators
Market Signals| Indicator | RPRX | TLN |
|---|---|---|
| Relative Strength Index (RSI) | 57.50 | 38.89 |
| Support Level | $39.24 | $359.52 |
| Resistance Level | $40.50 | $377.08 |
| Average True Range (ATR) | 0.91 | 18.51 |
| MACD | -0.08 | -1.00 |
| Stochastic Oscillator | 76.02 | 11.31 |
Price Performance
Historical ComparisonAbout RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About TLN Talen Energy Corporation Common Stock
Talen Energy Corp is an independent power producer and energy infrastructure company. The company owns and operates approximately 10.7 gigawatts of power infrastructure in the United States. The group produces and sells electricity, capacity, and ancillary services into wholesale U.S. power markets, including PJM and WECC, with its generation fleet located in the Mid-Atlantic and Montana.